Holen Sie sich die Stockscreener-App
33.05
2.51%
-0.86
Handel nachbörslich:
32.90
-0.15
-0.45%
Schlusskurs vom Vortag:
$33.91
Offen:
$32.868
24-Stunden-Volumen:
3.06M
Relative Volume:
0.49
Marktkapitalisierung:
$3.72B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-99.15M
KGV:
-35.54
EPS:
-0.93
Netto-Cashflow:
$-74.25M
1W Leistung:
+4.84%
1M Leistung:
+33.25%
6M Leistung:
+34.55%
1J Leistung:
-49.76%
1-Tages-Spanne:
$32.21
$34.09
1-Wochen-Bereich:
$31.66
$35.92
52-Wochen-Spanne:
$18.92
$81.73
Viking Therapeutics Inc Stock (VKTX) Company Profile
Firmenname
Viking Therapeutics Inc
Sektor
Branche
Telefon
858-704-4660
Adresse
9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA
Vergleichen Sie VKTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VKTX
Viking Therapeutics Inc
|
33.05 | 3.81B | 0 | -99.15M | -74.25M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-08 | Eingeleitet | Goldman | Neutral |
| 2025-02-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-02-07 | Eingeleitet | Citigroup | Neutral |
| 2024-12-02 | Eingeleitet | Piper Sandler | Overweight |
| 2024-11-22 | Eingeleitet | B. Riley Securities | Buy |
| 2024-11-04 | Bestätigt | H.C. Wainwright | Buy |
| 2024-09-11 | Eingeleitet | JP Morgan | Overweight |
| 2024-06-27 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-05-16 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-03-26 | Bestätigt | Oppenheimer | Outperform |
| 2024-03-07 | Eingeleitet | Jefferies | Buy |
| 2024-02-28 | Bestätigt | Oppenheimer | Outperform |
| 2023-05-31 | Fortgesetzt | ROTH MKM | Buy |
| 2023-03-28 | Bestätigt | Maxim Group | Buy |
| 2023-03-17 | Eingeleitet | Stifel | Buy |
| 2021-07-29 | Fortgesetzt | BTIG Research | Buy |
| 2021-05-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-06-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-05-05 | Eingeleitet | Chardan Capital Markets | Buy |
| 2020-05-01 | Eingeleitet | BTIG Research | Buy |
| 2019-07-16 | Eingeleitet | Oppenheimer | Outperform |
| 2019-06-25 | Eingeleitet | Stifel | Buy |
| 2019-03-29 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-03-14 | Bestätigt | Maxim Group | Buy |
| 2019-02-22 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2018-12-12 | Eingeleitet | B. Riley FBR | Buy |
| 2018-11-19 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-09-18 | Bestätigt | H.C. Wainwright | Buy |
| 2018-09-18 | Bestätigt | Maxim Group | Buy |
| 2018-09-18 | Bestätigt | Raymond James | Outperform |
| 2018-07-20 | Eingeleitet | SunTrust | Buy |
| 2018-06-28 | Eingeleitet | Raymond James | Outperform |
| 2018-06-01 | Bestätigt | Laidlaw | Buy |
| 2018-05-31 | Bestätigt | Maxim Group | Buy |
| 2018-03-26 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-11-28 | Bestätigt | Maxim Group | Buy |
| 2017-11-21 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Viking Therapeutics Inc Aktie (VKTX) Neueste Nachrichten
Earnings call transcript: Viking Therapeutics Q2 2025 sees increased R&D expenses - Investing.com
Is a relief rally coming for Viking Therapeutics Inc. holdersMarket Growth Summary & Verified Entry Point Signals - newser.com
What makes Viking Therapeutics Inc. stock attractive to growth fundsJuly 2025 News Drivers & Proven Capital Preservation Tips - newser.com
Live market analysis of Viking Therapeutics Inc.Chart Signals & Weekly High Return Stock Opportunities - newser.com
Using data models to predict Viking Therapeutics Inc. stock movementMarket Movement Recap & Free Technical Pattern Based Buy Signals - newser.com
How hedge fund analytics apply to Viking Therapeutics Inc. stock2025 Major Catalysts & Fast Entry and Exit Trade Plans - newser.com
Why Viking Therapeutics Inc. stock attracts high net worth investors2025 Valuation Update & Safe Capital Growth Stock Tips - newser.com
Can Viking Therapeutics Inc. stock hit record highs againMarket Volume Summary & Real-Time Buy Zone Alerts - newser.com
Key metrics from Viking Therapeutics Inc.’s quarterly dataWeekly Gains Summary & Long-Term Capital Growth Ideas - newser.com
Can trapped investors hope for a rebound in Viking Therapeutics Inc.Exit Point & High Accuracy Buy Signal Tips - newser.com
Down 44%, Should You Buy the Dip on Viking Therapeutics? - The Motley Fool
How to build a custom watchlist for Viking Therapeutics Inc.Volume Spike & Risk Managed Trade Strategies - newser.com
Is Viking Therapeutics Inc. stock oversold or undervaluedQuarterly Profit Review & AI Powered Market Entry Ideas - newser.com
Viking Therapeutics Inc. stock volume spike explained2025 Market Sentiment & Community Driven Trade Alerts - newser.com
How to integrate Viking Therapeutics Inc. into portfolio analysis tools2025 Market Overview & Free Accurate Trade Setup Notifications - newser.com
VKTX stock tumbles 29% today — Viking Therapeutics weight-loss trial results fuel massive investor sell-off and market jitters - MSN
Viking Therapeutics, Inc. $VKTX Shares Acquired by Blair William & Co. IL - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Shares Down 4.1%What's Next? - MarketBeat
Will a bounce in Viking Therapeutics Inc. offer an exitJuly 2025 Intraday Action & Daily Profit Focused Screening - newser.com
Sector ETF performance correlation with Viking Therapeutics Inc.2025 Buyback Activity & Free Long-Term Investment Growth Plans - newser.com
Why Akero Therapeutics Stock Trounced the Market on Thursday - AOL.com
Wealth Enhancement Advisory Services LLC Purchases New Stake in Viking Therapeutics, Inc. $VKTX - MarketBeat
Analyzing Viking Therapeutics Inc. with risk reward ratio charts2025 Price Action Summary & Verified Momentum Stock Ideas - newser.com
Viking Therapeutics (NASDAQ:VKTX) Stock Price Up 8.1%Should You Buy? - MarketBeat
Why Shares in Viking Therapeutics Surged This Week - sharewise.com
Viking Therapeutics (VKTX) Shares Surge Amid Acquisition Activit - GuruFocus
Viking Therapeutics (VKTX) Rises Amid Akero Therapeutics Acquisi - GuruFocus
Viking, Genfit, Sagimet jump on Novo- Akero deal (AKRO:NASDAQ) - Seeking Alpha
Volume spikes in Viking Therapeutics Inc. stock – what they meanJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
Visualizing Viking Therapeutics Inc. stock with heatmapsVolume Spike & Weekly High Momentum Picks - newser.com
Will Viking Therapeutics Inc. stock maintain momentum in 2025Trade Ideas & Growth Focused Entry Reports - newser.com
Think It's Too Late to Buy This Leading Biotech Stock? Here's Why There's Still Time. - MSN
Will Viking Therapeutics Inc. stock attract more institutional investorsJuly 2025 Rallies & Technical Pattern Alert System - newser.com
Viking Therapeutics, Inc. (NASDAQ:VKTX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Viking Therapeutics' (VKTX) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know - sharewise.com
Viking Therapeutics (NASDAQ:VKTX) Trading Up 2.6%Here's Why - MarketBeat
Where is Viking Therapeutics (VKTX) Headed According to Analysts? - MSN
Viking Therapeutics (NASDAQ:VKTX) Shares Down 2.3%Here's Why - MarketBeat
Viking Therapeutics Ignites Retail-Trader Frenzy Amid Deal Speculation, Upcoming Trial Catalysts - Stocktwits
Viking Therapeutics (NASDAQ:VKTX) Trading Up 8.6%Here's What Happened - MarketBeat
Why Viking Therapeutics (VKTX) Is Up 15.1% After Acquisition Buzz and Analyst Focus on Its Pipeline - Yahoo Finance
Finanzdaten der Viking Therapeutics Inc-Aktie (VKTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Viking Therapeutics Inc-Aktie (VKTX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| ZANTE GREG | Chief Financial Officer |
Jul 03 '25 |
Sale |
27.76 |
4,266 |
118,428 |
168,660 |
| Mancini Marianna | Chief Operating Officer |
Jul 03 '25 |
Sale |
27.77 |
4,266 |
118,473 |
377,535 |
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):